The more we extend our horizon, the more likely it is that stocks will provide juicy returns. Leading drugmaker Amgen could have several growth drivers through the end of the decade. Tepezza remains ...

Initial results found that among 1060 participants in 30 countries, the pembrolizumab plus CCRT group conferred better PFS at 24 months than the placebo plus CCRT group (68% vs 57%; hazard ratio [HR], ...

Adolescents with alopecia areata achieve hair regrowth with 80% or more of scalp coverage while taking the Janus kinase inhibitor baricitinib, a phase 3 study finds.

Pelczar was Vice President of Strategic Alliances and Cyber Security at Voltron Data, a leader in composable data systems, where he played a key role in driving strategic partnerships and expanding ...